Vimarsana
Biggest News Aggregation in the World

Interquartile Range News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Interquartile Range. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Interquartile Range Today - Breaking & Trending Today

REDUCE-AMI: No Benefit to Beta Blockers Post-Myocardial Infarction If LVEF is Normal - Vimarsana News

REDUCE-AMI: No Benefit to Beta Blockers Post-Myocardial Infarction If LVEF is Normal

REDUCE-AMI concluded beta-blockers show no significant benefit following myocardial infarction among patients with normal left ventricular ejection fraction

Unintentional Weight Loss Could Signal Elevated Risk of Cancer in Next 12 Months - Vimarsana News

Unintentional Weight Loss Could Signal Elevated Risk of Cancer in Next 12 Months

Study with 150,000 adults reveals 10% or more of unintentional weight loss associated with an elevated rate of cancer diagnosis within the next 12 months.

CLEAR Outcomes Analysis Finds Bempedoic Acid Reduces Total Cardiovascular Events by 20% - Vimarsana News

CLEAR Outcomes Analysis Finds Bempedoic Acid Reduces Total Cardiovascular Events by 20%

In the CLEAR Outcomes trial, bempedoic acid was associated with a 20% reduction in relative risk for total cardiovascular events, with further analysis shining light on the effects of specific types of events.

Lepodisiran, a Small Intefering RNA, Could Lower Lp(a) by More than 95% - Vimarsana News

Lepodisiran, a Small Intefering RNA, Could Lower Lp(a) by More than 95%

Presented at AHA 2023, phase 1 data for lepodisiran showcased a 97% reduction in lipoprotein(a) levels at the 608 mg dose.

ADHD Medications, Antidepressant Use Increasing in Youth with Type 1 Diabetes - Vimarsana News

ADHD Medications, Antidepressant Use Increasing in Youth with Type 1 Diabetes

A new study from Sweden is calling attention to disproportionate increases in psychotropic medication use among young people with type 1 diabetes relative to their counterparts without type 1 diabetes.